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We live in a world that inhibits many life forms including microorganisms. 
Bacteria, an important member of these microorganisms, sometimes become a 
very tough enemy of the human being with the stimulation of the conditions and 
environment. Bacterial infections that are sourced from pathogenic bacteria are one 
of the leading causes of the human death worldwide. For instance, lower respiratory 
infections killed 3 million people globally in 2016 [1].
Among the most pathogenic bacteria for human, genera of Staphylococcus 
and Streptococcus come forward with their pathogenicity. Staphylococci and 
Streptococci are grouped as Gram-positive cocci. Staphylococci form clumps, 
whereas Streptococci grow in chains. They can be discriminated by catalase test 
because Staphylococci have the capability to produce catalase [2].
Staphylococci and Streptococci are together responsible of the pathogenesis of a 
variety of diseases such as wound infections, mastitis, toxic shock syndrome, scarlet 
fever, cystic fibrosis, nosocomial and community-acquired infections, periodontitis, 
and indwelling device-associated infections [3, 4].
2. Virulence factors of Staphylococcus spp. and Streptococcus spp.
2.1 Toxins
As a major human pathogenic bacterium, Staphylococcus aureus (S. aureus) has 
many virulence factors including staphylocoagulase (SC), protein A, staphylococcal 
enterotoxins (SEs), and leukotoxins.
SC is the cause of acute bacterial endocarditis. It binds to the blood prothrombin, 
and this complex induces the number and the colonization of bacteria via transfor-
mation of fibrinogen to fibrin [5]. Protein A is the vehicle of S. aureus for binding to 
Fc region of IgG. By this mechanism, pathogenic bacterium is surrounded by IgG 
and will not be recognized by the cells of human immunity system [6].
SEs belong to a huge family of staphylococcal and streptococcal exotoxins and 
are shown to be the main cause of toxic shock syndrome. These superantigens show 
their pathogenicity via binding to class II major histocompatibility complex (MHC) 
molecules that are located on the surface of the antigen-presenting cells and causing 
a toxic shock with stimulation of high numbers of T cells [7].
Additionally, leukotoxins of S. aureus can eliminate phagocytic cells of the mam-
malian immune system by killing them selectively [8].
Staphylococcus and Streptococcus
2
Although they are the hosts of the mucosal surfaces of human, streptococci are 
associated with many infectious diseases like tonsillitis, endocarditis, pharyngitis, 
meningitis, and glomerulonephritis [9]. Group A streptococcus (GAS) which is 
known as the main cause of necrotizing fasciitis produce streptococcal pyrogenic 
exotoxins (Spes). Streptococcal toxic shock syndrome (STSS) is associated with 
various Spe proteins, including SpeA, SpeS and SpeG, streptococcal superantigen A 
(SSA), and streptococcal mitogenic exotoxin Z (SMEZ) and SMEZ2. As mentioned 
before, these superantigens induce T cells to proliferate massively and cause abnormal 
production of cytokines [10].
Hemolysin from Streptococcus pyogenes (S. pyogenes) and its equivalent, pneumo-
lysin, from S. pneumoniae, not only form pores but also activate the inflammatory 
system elements. Again, streptolysin O (SLO) and streptolysin S (SLS) belong to 
this superantigen family [10].
2.2 Biofilm formation
Bacterial biofilm is the optimum environment for bacteria to survive. More than 
a nutrient poll, biofilm provides protection for its residents against harsh conditions, 
antibiotics, and other antimicrobial chemical agents. From the vision of indwelling 
device-associated infections and nosocomial and community-acquired infections, 
Staphylococcus epidermidis (S. epidermidis) and S. aureus are the main responsible 
organisms with the ability of forming biofilm [11].
S. aureus strains can bear the ica operon that express polysaccharide intracellular 
adhesin (PIA) which is termed as the main molecule in biofilm formation [12, 13]. 
With its positively charged molecular structure, PIA enhances the intercellular 
binding of negatively charged bacterial surface [14].
However, the biofilm can be structured without the adhesive effect of 
PIA. PIA-independent biofilms may be formed by different surface proteins such 
as biofilm-associated protein (Bap) and accumulation-associated proteins (Aap) 
of S. epidermidis [12, 13]. More than that, protein A and some members of the 
fibronectin-binding proteins, cell wall-anchored proteins, and autolysins can help 
the formation of biofilm [14].
3. Antibiotic resistance of Staphylococcus and Streptococcus
Antibiotic resistance becomes a worldwide serious health threat due to the 
inappropriate prescribing, overuse, and the extensive agricultural use of antibiotics 
[15]. S. aureus, a well-known pathogenic bacterium, exhibits resistance to the some 
of the important and widely used antibiotics such as β-lactam antibiotics, tetracy-
cline, and methicillin through its genome and extrachromosomal elements [16].
The genetic elements of S. aureus play a critical role in antibiotic resistance. 
S. aureus can hydrolase the β-lactam ring of penicillin by using the penicillinase 
which is expressed from the blaZ gene localized in S. aureus plasmid. This emerging 
feature can be observed more than 80 percent of the S. aureus strains [17].
Another example of plasmid-originated antibiotic resistance can be observed 
for tetracycline in S. aureus. Tet gene in conjugative plasmid of S. aureus encodes 
ribosomal protection protein which prevents the binding of tetracycline to ribo-
some and thus the inactivation of it [18].
The occurrence of S. aureus isolates that are resistant to β-lactam antibiotics 
provide the discovery of penicillinase-stable penicillins. One of these molecules, 
methicillin, is the medication of choice to treat β-lactam-resistant S. aureus infections. 
But some of the S. aureus isolates are also resistant to methicillin and different types 
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of antibiotics such as macrolides and cephalosporins. Methicillin-resistant S. aureus 
(MRSA) isolates demonstrate their characteristics of multi-antibiotic resistance 
through their chromosomes and extrachromosomal elements. Penicillin binding pro-
tein 2a which is encoded by chromosomal mecA gene is the main reason of methicillin 
resistance of S. aureus [19, 20].
Enterococci are the members of the microflora of the intestinal system. 
But they are also opportunistic and nosocomial pathogens. Especially, they are 
accused of sepsis, endocarditis, and urinary tract infections in immunosuppressed 
patients [21].
These pathogens demonstrate a different feature compared to other Gram-
positive cocci: adaptation to different antimicrobials such as vancomycin quickly 
and exhibition of multidrug resistance [21].
Vancomycin is a member of glycopeptide antibiotics. It targets the precursors of 
peptidoglycan, while this system is crucial for the enterococcal cell wall biosynthe-
sis. By binding to these precursors and preventing the transglycosylation and trans-
peptidation, vancomycin prevents the building and growing of bacterial cell wall 
[22]. But enterococci overcome this destructive problem with different van operon 
systems, for instance, vanA, vanB, vanC, and vanD. The common feature of these 
systems is to alter the peptidoglycan biosynthesis pathway with different molecules 
so that vancomycin cannot identify the molecule thus cannot interfere [22].
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